The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.
Analysts at Axis Securities believe Nifty's strong June rollovers suggest a likely bullish conviction for the July series.
Stocks to Watch today, June 3: Infosys, Alkem Labs, Paytm among others in focus; here's why
The company has received DCGI approval for multiple dosage strengths and aims to widen access to semaglutide treatment for diabetes and obesity
Stocks to Watch, June 2: L&T, Anant Raj, Ola Electric, Paytm, Alkem Labs among shares to remain on investors' and traders' radar today
In the March quarter, Alkem Laboratories reported a fall in consolidated net profit by 22.7 per cent year-on-year (Y-o-Y) for the fourth quarter (Q4) of the financial year 2025-26 (FY26) to ₹236 crore
Stocks to Watch today, May 29, 2026: Ashok Leyland, Alkem Laboratories, PhysicsWallah, GMR Airports, InterGlobe Aviation, NMDC, and Glenmark Pharma are among the top stocks to remain in focus today
The drugmaker said strong domestic branded generics and international business growth helped drive record EBITDA performance in FY26
Q4FY26 company results: Firms including Bharat Dynamics, Schneider Electric Infra, Deepak Fertilisers & Petrochemicals, and Apar Industries are also to release their January-March earnings today